GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HMGCR, HSD17B1, HSPA1A, INSR, KDR, KIT, MET, PPARA, PTAFR, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
11.9656 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
10.5895 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
10.5895 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ERBB2, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
10.5895 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ERBB2, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
10.5071 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, PPARA, PTAFR, RORC, SMAD3, SRC, TEK |
9.6939 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MMP12, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
9.06138 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, KIT, NUAK1, PPARA, PTAFR, SMAD3, SRC, TEK, XDH |
8.66916 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, KIT, NUAK1, PPARA, PTAFR, SMAD3, SRC, TEK, XDH |
8.62786 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.62548 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, FABP3, FABP4, FUT7, HMGCR, HSD17B1, KIT, MET, PPARA |
8.6149 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CYP1B1, EGFR, ERBB2, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, SRC, TEK, XDH |
8.53839 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ERBB2, FABP3, FLT3, GRM5, IGF1R, INSR, KIT, PPARA, PTAFR, SMAD3, SRC, TEK |
8.50931 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, PPARA, PTAFR, RORC, SMAD3, SRC, TEK |
8.43988 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX15, APP, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, GPR35, GRIK5, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PPARA, PTAFR, SMAD3, SRC, TEK |
7.8396 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, BCL2, CA1, CSNK2A1, EGFR, ERBB2, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PTAFR, SMAD3, SRC, TEK, TNKS, TNKS2 |
7.61709 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MMP12, PTAFR, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
7.57337 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7, GRM5, PTAFR |
7.18435 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.14488 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MMP12, NUAK1, PTAFR, SMAD3, SRC, TEK, XDH |
7.14488 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, PTAFR, RORC, SMAD3, SRC |
7.14488 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CYP1A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, KIT, PTAFR, RORC, SMAD3, SRC |
7.08656 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ERBB2, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, SRC, TEK, XDH |
7.02376 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, KIT, PTAFR, SMAD3, SRC, TEK, XDH |
7.01137 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, KIT, PTAFR, SMAD3, SRC, TEK, XDH |
7.01137 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT |
6.92896 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, KIT |
6.92896 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, KIT, PPARA, PTAFR, SRC, TEK |
6.91046 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.84731 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, GRIK5, GRM5, HMGCR, IGF1R, INSR, PPARA, PTAFR, RORC, SRC, TEK |
6.84731 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CACNA1C, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, INSR, KDR, KIT, MET, PTAFR, SMAD3, SRC, TEK |
6.84731 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.71584 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.71584 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.66492 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, INSR, KDR, KIT, MET, PTAFR, SMAD3, SRC, TEK |
6.53499 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, SRC, TEK |
6.52719 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, EGFR, ERBB2, FLT3, GRM1, HMGCR, INSR, KDR, KIT, SRC, TEK, XDH |
6.50743 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DUSP3, EGFR, ERBB2, FLT3, GRM1, HMGCR, IGF1R, INSR, KDR, KIT, SRC, TEK, XDH |
6.49428 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3, SRC |
6.47097 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, FABP3, FABP4, FUT7, HMGCR, KIT, MET, PPARA |
6.43198 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PPARA, PTAFR, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.39539 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, HMGCR, HSPA1A, PPARA, PTAFR, XDH |
6.23052 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.23052 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.22401 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ERBB2, FABP4, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
6.15961 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, INSR, KDR, KIT, MET, PTAFR, SMAD3, SRC, TEK |
6.11121 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, KIT, MET, PTAFR, SMAD3, SRC, TEK |
6.11121 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, KIT, SRC |
6.09682 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, APP, BCL2, CSNK2A1, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KIT, NUAK1, PTAFR, SMAD3, SRC, TEK, TNKS, XDH |
5.95397 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, BCL2, CSNK2A1, DUSP3, EGFR, ERBB2, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PTAFR, PTPRS, SRC, TEK, TNKS, XDH |
5.91945 |
[BP] GO:0048513 |
animal organ development
|
ACHE, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, FLT3, INSR, KDR, KIT, PPARA, PTPRS, SMAD3, SRC, TEK |
5.91945 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ERBB2, FLT3, GPR35, GRM1, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.9031 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, SMAD3 |
5.78203 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.75502 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, ERBB2, PPARA, SMAD3 |
5.74632 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, ADRB1, APP, BCL2, CSNK2A1, CYP1B1, DUSP3, EGFR, ERBB2, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KIT, MET, NUAK1, PPARA, PTAFR, SMAD3, SRC, TEK, TNKS, XDH |
5.71815 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, APP, BCL2, CA2, CA7, CACNA1C, CYP19A1, EGFR, ERBB2, GPR35, GRIK5, GRM5, HMGCR, HSPA1A, INSR, MMP12, PPARA, PTAFR, SMAD3, SRC |
5.67034 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, PTAFR, RORC, SRC, TEK |
5.64215 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, BCL2, CSNK2A1, DUSP3, EGFR, ERBB2, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PTAFR, PTPRS, SRC, TEK, TNKS, XDH |
5.58277 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, ERBB2, FLT3, GRM1, HMGCR, IGF1R, INSR, KIT, SRC |
5.52042 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.48938 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, KIT, NUAK1, PTAFR, RORC, SMAD3, SRC |
5.48938 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, APP, BCL2, CA2, CYP1A1, EGFR, GRM1, HMGCR, HSPA1A, KIT, PPARA, PTAFR, SMAD3, SRC, TEK |
5.45668 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, EGFR, IGF1R, INSR, KDR, KIT, MET, PTAFR, SMAD3, SRC, TEK |
5.38935 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, EGFR, IGF1R, INSR, KDR, KIT, MET, PTAFR, SMAD3, SRC, TEK |
5.22869 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.16722 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
5.16642 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, KIT, PPARA, SRC, TEK, XDH |
5.12141 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, EGFR, IGF1R, INSR, KDR, KIT, MET, PTAFR, SMAD3, SRC, TEK |
5.11395 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.09367 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, EGFR, GRM1, GRM3, GRM5, GRM8 |
5.07452 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, KIT, SRC, TEK, XDH |
5.02339 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KDR, KIT, SRC, TEK, XDH |
4.9965 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.9931 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, EGFR, IGF1R, INSR, KDR, KIT, MET, PTAFR, SMAD3, SRC, TEK |
4.9765 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, CACNA1C, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
4.89311 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, ALOX15, ALPL, APP, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, FABP4, GRM1, GRM5, GRM8, HMGCR, IGF1R, INSR, KIT, MET, MMP12, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS2 |
4.89311 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.86978 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, APP, BCL2, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, NUAK1, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS, TNKS2 |
4.86145 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KIT, SRC, TEK |
4.86145 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, APP, BCL2, CA2, CACNA1C, CYP1B1, EGFR, ERBB2, GPR35, GRM1, HMGCR, HSPA1A, INSR, KDR, KIT, MET, MMP12, PTAFR, PTPRS, SLC1A1, SMAD3, SRC, TEK, TNKS2, XDH |
4.81298 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, KIT, SRC, TEK, XDH |
4.81221 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, CSNK2A1, EGFR, ERBB2, FABP3, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.78204 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MMP12, NUAK1, PPARA, PTAFR, RORC, SMAD3, SRC, TEK |
4.75215 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, NUAK1, SRC, TEK, XDH |
4.74951 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
4.74146 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.72501 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, HMGCR, HSD17B1 |
4.71943 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, KIT, PTAFR, SMAD3, SRC, TEK, XDH |
4.69629 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KIT, SRC, TEK, TNKS |
4.69219 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, APP, CYP19A1, DUSP3, EGFR, FABP4, HMGCR, HSPA1A, IGF1R, MET, MMP12, NUAK1, PPARA, PTPRS, SMAD3, SRC, TEK, XDH |
4.68361 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.6244 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, IGF1R, INSR, KIT, SRC |
4.47254 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ERBB2, FABP4, FLT3, FUT7, HMGCR, INSR, KDR, KIT, MET, PPARA, PTPRS, RORC, SMAD3, SRC, TEK, TNKS2 |
4.47254 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, HSPA1A, INSR, KDR, KIT, PTAFR, SMAD3, SRC, TEK, XDH |
4.39234 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, SRC, TEK, TNKS |
4.37801 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DUSP3, EGFR, ERBB2, HMGCR, KDR, SRC, TEK |
4.3763 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HMGCR, KIT, PPARA, RORC, SRC, TEK |
4.3643 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7, GRM5, PTAFR |
4.34098 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
4.3405 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, PPARA, SMAD3, SRC, TEK |
4.30653 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
4.29544 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, BCL2, CA2, CA7, CACNA1C, EGFR, HMGCR, KDR, SRC, TNKS, TNKS2 |
4.25862 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, ADRB1, APP, BCL2, EGFR, ERBB2, FLT3, GRM1, GRM5, HSPA1A, INSR, KIT, MET, PTAFR, SMAD3, SRC, TEK, TNKS, XDH |
4.24046 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRB1, APP, BCL2, EGFR, ERBB2, FLT3, GRM1, GRM5, HSPA1A, INSR, KIT, PTAFR, SMAD3, SRC, TEK, TNKS, XDH |
4.20624 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
EGFR, ERBB2, INSR, KIT, MET, SRC, TEK, XDH |
4.19473 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.17443 |
[BP] GO:0033993 |
response to lipid
|
ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, PTAFR, RORC, SRC |
4.14662 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
4.14244 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, ERBB2, FLT3, GRM1, HMGCR, IGF1R, INSR, KIT, SRC |
4.04047 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, SMAD3, SRC, TEK |
4.03692 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, ERBB2, INSR, KIT, MET, SRC, TEK |
4.0354 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, PPARA, SMAD3, SRC, TEK, XDH |
4.00987 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.98976 |
[BP] GO:0003018 |
None
|
ADORA1, ADRB1, EGFR, HMGCR, PTAFR, SRC, TEK |
3.98976 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, BCL2, CYP19A1, DUSP3, EGFR, ERBB2, HMGCR, HSPA1A, IGF1R, MET, MMP12, PPARA, PTPRS, SMAD3, SRC, TEK, XDH |
3.96277 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, HMGCR, IGF1R, INSR, KDR, KIT, MMP12, PTAFR, TEK |
3.96277 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APP, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, GPR35, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, MMP12, PPARA, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.94454 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, BCL2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, GPR35, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, MMP12, PPARA, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.94454 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, EGFR, GPR35, GRM1, KIT, PTAFR, SLC1A1, SMAD3 |
3.93857 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ERBB2, FLT3, INSR, KDR, KIT, PPARA, PTPRS, RORC, SMAD3, SRC, TEK |
3.92231 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, KIT |
3.91471 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, KIT, MET, SMAD3, SRC, TEK, XDH |
3.84042 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.81484 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.81484 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, EGFR, ERBB2, FLT3, GRM1, GRM5, HMGCR, INSR, KDR, KIT, SRC, TEK, XDH |
3.81319 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.75552 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, FABP3, GPR35, GRM1, GRM5, SMAD3 |
3.7244 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CYP1B1, DUSP3, ERBB2, KDR, NUAK1, PPARA, PTAFR, SMAD3, SRC, TEK |
3.7244 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.7244 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CSNK2A1, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, NUAK1, PTAFR, SMAD3, SRC, TEK, XDH |
3.67181 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, EGFR, ERBB2, FLT3, GRM5, IGF1R, INSR, KIT, PTAFR, SMAD3, SRC |
3.64017 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GRM5, IGF1R, INSR, PPARA, SRC, TEK |
3.62903 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, EGFR, FLT3, PTAFR, RORC, SRC |
3.61116 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, BCL2, CA2, CYP19A1, EGFR, ERBB2, INSR, MMP12, PTAFR, SMAD3, SRC |
3.58034 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, INSR, KIT, SRC |
3.55978 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DUSP3, EGFR, ERBB2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP12, PTPRS, SMAD3, SRC, XDH |
3.50754 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.4949 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DUSP3, EGFR, ERBB2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP12, PTPRS, SMAD3, SRC, XDH |
3.4949 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, PTPRS, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, TUBB3, XDH |
3.48468 |
[BP] GO:0010359 |
None
|
ABCB1, GRM5, PTAFR |
3.48453 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, SRC, TEK |
3.4505 |
[BP] GO:0016310 |
phosphorylation
|
APP, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, SRC, TEK, TNKS |
3.40432 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, HMGCR, KDR, SRC, TEK |
3.387 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC, TEK |
3.37108 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, BCL2, CA9, CYP1A1, CYP1B1, EGFR, FABP3, HMGCR, KDR, PTAFR, SRC |
3.35478 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.35478 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
3.35478 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK, TNKS |
3.32877 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, APP, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.32877 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, BCL2, HSPA1A, INSR, KDR, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
3.31984 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
3.30702 |
[BP] GO:0003013 |
None
|
ADORA1, ADRB1, EGFR, HMGCR, PTAFR, SRC, TEK |
3.30452 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRB1, ALOX15, APP, BCL2, CA9, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.29751 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
3.28345 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, KDR, SRC |
3.26944 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, ERBB2, PPARA, SMAD3 |
3.26175 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.26175 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRB1, AKR1B1, BCL2, CACNA1C, CYP1B1, EGFR, ERBB2, GRM5, IGF1R, INSR, KDR, KIT, MET, NUAK1, PTAFR, SRC, TEK |
3.25366 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.25134 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, HMGCR, HSD17B1 |
3.25017 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, PPARA, PTAFR, SRC, TEK |
3.24685 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, APP, BCL2, CA2, CYP1B1, EGFR, HMGCR, HSPA1A, KDR, KIT, MET, MMP12, PTAFR, SLC1A1, SMAD3, SRC, TEK |
3.23542 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, KIT, MET |
3.20227 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, GPR35, GRM1, GRM5, SMAD3 |
3.17667 |
[BP] GO:0003008 |
None
|
ADORA1, ADRB1, AKR1B1, APP, BCL2, CYP1B1, EGFR, GRM1, GRM5, GRM8, HMGCR, INSR, KIT, PTAFR, SRC, TEK |
3.15774 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CSNK2A1, DUSP3, EGFR, ERBB2, FABP4, FLT3, GRM1, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, NUAK1, PTAFR, SMAD3, SRC, TEK, XDH |
3.1475 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, PTAFR, SRC |
3.1475 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, EGFR, FABP4, HMGCR, KDR, MET, MMP12, PPARA, PTPRS, SMAD3, TEK |
3.13089 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, HMGCR, SRC, TNKS, TNKS2 |
3.13089 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, HMGCR, PTAFR |
3.13089 |
[BP] GO:0040008 |
regulation of growth
|
ADRB1, APP, BCL2, CSNK2A1, EGFR, ERBB2, HSPA1A, INSR, PTPRS, SMAD3, TNKS2 |
3.12304 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, BCL2, CYP1A1, EGFR, ERBB2, FLT3, KIT, MET, SRC, TEK |
3.11874 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRB1, ALOX15, APP, BCL2, CA9, CSNK2A1, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.11179 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, APP, BCL2, CA9, CSNK2A1, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
3.06323 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, GRM5, KIT, SRC |
3.01794 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, GRM5, INSR, KIT, SRC, TEK |
3.00931 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, SMAD3, SRC, TEK |
3.00931 |
[BP] GO:0045776 |
None
|
ADORA1, ADRB1, PPARA, PTAFR |
3.00537 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, PTAFR, SRC |
2.97677 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.96963 |
[BP] GO:0007188 |
None
|
ADORA1, ADRB1, GRM1, GRM3, GRM5, GRM8 |
2.96455 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.96334 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, PPARA, PTAFR, SRC, TEK |
2.96334 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, GRM5, INSR, KIT, SRC, TEK, TNKS |
2.96211 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
2.94215 |
[BP] GO:0006811 |
None
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, FABP3, GRIA2, GRIA4, GRIK5, PPARA, SLC1A1 |
2.88146 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, ERBB2, INSR, KDR, SMAD3, SRC |
2.88001 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, KIT, TEK |
2.84174 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, INSR, KIT, SRC |
2.80056 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, SMAD3, SRC, TEK |
2.80056 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, SMAD3, XDH |
2.78859 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, CSNK2A1, CYP1B1, DUSP3, FABP4, GPR35, GRM3, HMGCR, IGF1R, MET, PPARA, SRC, TNKS |
2.78048 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, GRIK5, INSR, SLC1A1, SMAD3 |
2.78033 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, GRIK5, HMGCR, HSPA1A, IGF1R, KDR, SMAD3, SRC, TEK, XDH |
2.77703 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, PTPRS, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.77386 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, SMAD3, TEK |
2.76912 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, BCL2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.76912 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALPL, APP, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PPARA, PTAFR, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.76912 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.7567 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, PPARA, SMAD3, SRC, TEK |
2.74891 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.73957 |
[BP] GO:0032787 |
None
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
2.69859 |
[BP] GO:0010676 |
None
|
INSR, PPARA, PTAFR, SRC |
2.68523 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.68523 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, PTAFR, SRC |
2.68523 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, PPARA, SMAD3, SRC, TEK |
2.67456 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, APP, BCL2, CA2, CA7, CACNA1C, GPR35, GRM5, PTAFR |
2.67456 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 |
2.65172 |
[BP] GO:0050789 |
regulation of biological process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA1, CA2, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, PTPRS, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.64575 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B1, XDH |
2.63732 |
[BP] GO:0050890 |
None
|
ADORA1, APP, EGFR, GRM5, HMGCR, INSR, KIT |
2.63475 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.63475 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.63475 |
[BP] GO:0007187 |
None
|
ADORA1, ADRB1, GRM1, GRM3, GRM5, GRM8 |
2.63384 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, CYP1B1, EGFR, GRIK5, GRM5, IGF1R, INSR, PTAFR, RORC, SRC |
2.63277 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 |
2.61502 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, HSPA1A, KIT, NUAK1, PPARA, PTAFR, SMAD3, SRC, TEK |
2.61502 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.61502 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.61462 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.61462 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.61462 |
[BP] GO:0055080 |
cation homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, EGFR, GPR35, GRM1, GRM5, SMAD3 |
2.59011 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, KDR, SMAD3, SRC, TEK |
2.59011 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, HMGCR, PPARA, PTPRS, SMAD3, TEK |
2.59011 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, ERBB2, INSR, KDR, SMAD3, SRC |
2.59011 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, TEK |
2.57644 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, RORC |
2.57644 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.57089 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, MET, SMAD3, SRC |
2.5669 |
[BP] GO:0035588 |
None
|
ADORA1, ADORA3, PTAFR |
2.56686 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.56421 |
[BP] GO:0048511 |
rhythmic process
|
BCL2, CSNK2A1, EGFR, KIT, PPARA, RORC, SRC |
2.55186 |
[BP] GO:0007423 |
None
|
BCL2, CACNA1C, CYP1A1, EGFR, KIT |
2.54912 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, EGFR, PTAFR, SLC1A1 |
2.54512 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, GRM1, GRM5, INSR, KIT, SRC |
2.52374 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, EGFR, GRM5, IGF1R, INSR, PTAFR, SRC |
2.52374 |
[BP] GO:1903959 |
None
|
ABCB1, GRM5, PTAFR |
2.51704 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, FABP4, HSPA1A, MMP12, PPARA, PTPRS, SMAD3, SRC, TEK |
2.50511 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, PPARA, SMAD3, SRC, TEK |
2.50079 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, NUAK1, PTPRS, XDH |
2.49904 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR |
2.48499 |
[BP] GO:0010675 |
None
|
INSR, PPARA, PTAFR, RORC, SRC |
2.48499 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, GPR35, GRIK5, GRM1, GRM5, SMAD3 |
2.48499 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, BCL2, CYP1A1, CYP1B1, HMGCR, KDR, SRC |
2.48499 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, APP, EGFR, ERBB2, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, PTAFR, RORC, SMAD3, SRC, TNKS, TNKS2 |
2.47613 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, HSPA1A |
2.45288 |
[BP] GO:0097746 |
None
|
ADORA1, ADRB1, EGFR, HMGCR, PTAFR |
2.44047 |
[BP] GO:0035296 |
None
|
ADORA1, ADRB1, EGFR, HMGCR, PTAFR |
2.44047 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, HMGCR |
2.4252 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, ALPL, APP, BCL2, CBR1, CYP1A1, EGFR, ERBB2, FABP4, FLT3, FUT7, HMGCR, KDR, KIT, MET, PTPRS, RORC, SMAD3, SRC, TEK |
2.41711 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.41711 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CACNA1C, EGFR, ERBB2, HMGCR, MMP12, SMAD3, SRC |
2.40629 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GRM5, IGF1R, INSR, SRC |
2.3968 |
[BP] GO:0007610 |
None
|
APP, BCL2, EGFR, GRM1, GRM5, HMGCR, INSR, KIT, PPARA |
2.38995 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, BCL2, CACNA1C, EGFR, GPR35, GRM1, GRM5, SMAD3 |
2.383 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRB1, APP, BCL2, CA2, CYP1B1, EGFR, ERBB2, HMGCR, INSR, KDR, KIT, NUAK1, PPARA, PTPRS, RORC, SMAD3, SRC, TEK, TNKS2, XDH |
2.383 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.383 |
[BP] GO:1901529 |
None
|
ABCB1, PTAFR |
2.383 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.383 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, KDR, KIT, TEK |
2.38145 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.38145 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.38145 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.38145 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CACNA1C, CYP19A1, EGFR, GRIK5, HMGCR, MMP12, PTAFR, SRC |
2.36161 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
EGFR, IGF1R, INSR, SRC, TNKS, TNKS2 |
2.36161 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
ADRB1, APP, BCL2, TNKS2 |
2.36161 |
[BP] GO:0050880 |
None
|
ADORA1, ADRB1, EGFR, HMGCR, PTAFR |
2.3431 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, HMGCR, IGF1R, XDH |
2.34216 |
[BP] GO:0045913 |
None
|
INSR, PPARA, PTAFR, SRC |
2.34017 |
[BP] GO:0048169 |
None
|
APP, GRM5, KIT |
2.33862 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, EGFR, GRM5, IGF1R, INSR, PTAFR, SRC |
2.33862 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, HMGCR, IGF1R, XDH |
2.33862 |
[BP] GO:0035150 |
None
|
ADORA1, ADRB1, EGFR, HMGCR, PTAFR |
2.33767 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.32537 |
[BP] GO:0031644 |
None
|
ADORA1, GPR35, GRM1, PTAFR |
2.30363 |
[BP] GO:1903524 |
None
|
ADRB1, EGFR, PTAFR, SLC1A1 |
2.30363 |
[BP] GO:0007612 |
None
|
APP, GRM5, HMGCR, INSR, KIT |
2.30363 |
[BP] GO:0023052 |
None
|
ADORA1, ADRB1, CACNA1C, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.30363 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.30363 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, BCL2, CYP1B1, ERBB2, FABP3, HSPA1A, SMAD3, XDH |
2.27976 |
[BP] GO:0034762 |
None
|
ABCB1, APP, BCL2, CA2, CACNA1C, GPR35, GRM5, PTAFR |
2.27976 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, GPR35, GRM1, GRM5, SMAD3 |
2.27614 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, EGFR, FLT3, PTAFR |
2.26649 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.26425 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.26425 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, BCL2, CA2, CYP19A1, DUSP3, ERBB2, HSPA1A, KIT, MMP12, PTAFR, PTPRS, SMAD3, SRC |
2.26077 |
[BP] GO:0050678 |
None
|
EGFR, ERBB2, KDR, MMP12, SMAD3, TEK, XDH |
2.24072 |
[BP] GO:0022898 |
None
|
ABCB1, APP, BCL2, GPR35, GRM5, PTAFR |
2.23724 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DUSP3, EGFR, ERBB2, HMGCR, HSPA1A, IGF1R, MET, MMP12, PTPRS, SMAD3, SRC, XDH |
2.23547 |
[BP] GO:0035587 |
None
|
ADORA1, ADORA3, PTAFR |
2.22316 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, BCL2, CSNK2A1, EGFR, ERBB2, GRIK5, HSPA1A, IGF1R, INSR, KDR, KIT, MET, PTPRS, SMAD3, SRC, TEK, TNKS, TNKS2 |
2.2189 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.2189 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, BCL2, CA2, CA7, CACNA1C, GPR35, GRM1, GRM5, SMAD3 |
2.21481 |
[BP] GO:0007154 |
None
|
ADORA1, ADRB1, BCL2, CACNA1C, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.21481 |
[BP] GO:0006650 |
glycerophospholipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, ERBB2, KIT, MET |
2.20372 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, PTAFR |
2.19714 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APP, BCL2, CA1, CA2, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, PTPRS, RORC, SMAD3, SRC, TEK, TNKS, TNKS2, XDH |
2.18413 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, BCL2, CSNK2A1, DUSP3, EGFR, FABP4, GRM3, GRM8, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP12, PPARA, RORC, SMAD3, SRC, TNKS, TNKS2, XDH |
2.18413 |
[BP] GO:0007611 |
None
|
APP, EGFR, GRM5, HMGCR, INSR, KIT |
2.1803 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.17959 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4 |
2.16249 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CACNA1C, CYP19A1, EGFR, GRIK5, HMGCR, MMP12, PTAFR, SRC |
2.15954 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, BCL2, CYP1B1, EGFR, HSPA1A, SRC |
2.15954 |
[BP] GO:0051098 |
regulation of binding
|
APP, BCL2, MET, PPARA, SMAD3, SRC, TNKS |
2.15954 |
[BP] GO:0008217 |
None
|
ADORA1, ADRB1, PPARA, PTAFR, SMAD3 |
2.15437 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.15363 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GRM5, IGF1R |
2.15363 |
[BP] GO:0019637 |
organophosphate metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, ERBB2, HMGCR, HSPA1A, KIT, MET, PTAFR, XDH |
2.14895 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, FLT3, KIT |
2.14747 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3 |
2.12522 |
[BP] GO:0032409 |
None
|
ABCB1, APP, BCL2, GPR35, GRM5, PTAFR |
2.12522 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.11705 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, ADRB1, APP, BCL2, CA9, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, GRM3, GRM5, GRM8, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, PPARA, PTAFR, RORC, SMAD3, SRC, TNKS, TNKS2 |
2.11506 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, APP, EGFR, ERBB2, FABP3, IGF1R, INSR, MET, MMP12, PPARA, PTAFR, RORC, SMAD3, SRC, TNKS, TNKS2 |
2.1076 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.0934 |
[BP] GO:0048729 |
tissue morphogenesis
|
BCL2, CA2, CA9, EGFR, MET, SMAD3, SRC |
2.08381 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.08353 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, KIT, PTAFR |
2.08353 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.08353 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.08353 |
[BP] GO:1903961 |
None
|
ABCB1, PTAFR |
2.08353 |
[BP] GO:1904306 |
None
|
KIT, PTAFR |
2.08353 |
[BP] GO:1904304 |
None
|
KIT, PTAFR |
2.08353 |
[BP] GO:0051234 |
None
|
ABCB1, ACHE, ADORA1, ALOX15, APP, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, EGFR, FABP3, GRIA2, GRIA4, GRIK5, HSPA1A, KIT, MMP12, PPARA, PTAFR, SLC1A1, SRC, TNKS, XDH |
2.05752 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
EGFR, KIT, PTAFR |
2.05523 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.05523 |
[BP] GO:0106027 |
None
|
APP, IGF1R, INSR |
2.05523 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, HSPA1A, KDR, KIT, MET, SMAD3, SRC, TEK |
2.04072 |
[BP] GO:0051930 |
None
|
ADORA1, GRM1, PTAFR |
2.02027 |
[BP] GO:0051931 |
None
|
ADORA1, GRM1, PTAFR |
2.02027 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, HMGCR, PTAFR |
2.01979 |
[BP] GO:0007267 |
None
|
ADORA1, ADRB1, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1, TEK |
2.01671 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, ADRB1, ALOX15, APP, CA2, CA4, CA9, CACNA1C, DUSP3, EGFR, ERBB2, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PTAFR, PTPRS, SLC1A1, SRC, TEK |
8.42109 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, CA2, CA4, CA9, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, SLC1A1, SRC, TEK |
7.00703 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALPL, APP, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, EGFR, ERBB2, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PTAFR, PTPRS, SLC1A1, SMAD3, SRC, TEK |
6.48514 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALPL, APP, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ERBB2, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, KIT, MET, PTAFR, PTPRS, SLC1A1, SRC, TEK |
5.91945 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALPL, APP, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, KIT, MET, PTAFR, PTPRS, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2 |
5.6661 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRB1, APP, CA4, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTAFR, PTPRS, SLC1A1, TEK |
5.283 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRB1, APP, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTAFR, PTPRS, SLC1A1, TEK |
4.89311 |
[CC] GO:0043235 |
receptor complex
|
APP, EGFR, ERBB2, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 |
4.78204 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTPRS, SRC |
4.29916 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.6468 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2, TEK |
3.52865 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
3.37728 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, GRIK5, GRM1, GRM3, GRM5, SRC |
3.37728 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTPRS, SRC, TUBB3 |
3.0886 |
[CC] GO:0097458 |
None
|
ADORA1, APP, CA2, CACNA1C, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, PTPRS, SRC, TUBB3 |
2.59011 |
[CC] GO:0097060 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.52878 |
[CC] GO:0043197 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.52374 |
[CC] GO:0044309 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.49594 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTPRS, SRC, TEK, TUBB3 |
2.36378 |
[CC] GO:0031224 |
None
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALPL, APP, CA12, CA14, CA4, CA9, CACNA1C, EGFR, ERBB2, FLT3, FUT7, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, HMGCR, IGF1R, INSR, KDR, KIT, MET, PTAFR, PTPRS, SLC1A1, TEK |
2.30363 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTPRS, SRC, TEK, TUBB3 |
2.16227 |
[CC] GO:0098794 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.12149 |
[CC] GO:0044464 |
cell part
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, PTPRS, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, TUBB3, XDH |
2.08588 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, ALPL, APP, BCL2, CA1, CA2, CA4, CA9, CACNA1C, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, FUT7, GRIA4, GRIK5, GRM1, GRM3, GRM5, HMGCR, HSPA1A, IGF1R, INSR, KDR, KIT, MMP12, NUAK1, PPARA, PTPRS, RORC, SLC1A1, SMAD3, SRC, TNKS, TNKS2, TUBB3, XDH |
2.03307 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.1961 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
9.00565 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.49539 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALPL, APP, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ERBB2, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PPARA, PTAFR, PTPRS, RORC, SLC1A1, SMAD3, SRC, TEK, TNKS, TNKS2, TUBB3, XDH |
8.39417 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.36481 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, EGFR, ERBB2, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PPARA, PTAFR, RORC, TEK |
7.69396 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, INSR, KDR, KIT |
7.46726 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MMP12, PPARA, RORC, SMAD3, TNKS, XDH |
7.1522 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRB1, EGFR, ERBB2, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PTAFR, TEK |
6.93676 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRB1, EGFR, ERBB2, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PTAFR, TEK |
6.93676 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.92896 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, EGFR, ERBB2, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PPARA, PTAFR, RORC, TEK |
6.91046 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, EGFR, ERBB2, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PPARA, PTAFR, RORC, SMAD3, TEK |
6.88975 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, SRC, TEK |
6.80486 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, EGFR, ERBB2, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, KIT, MET, PPARA, PTAFR, RORC, TEK |
6.71584 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.67083 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, ALOX15, ALPL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ERBB2, FLT3, FUT7, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP12, NUAK1, PTPRS, SRC, TEK, TNKS, TNKS2, TUBB3, XDH |
6.43644 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.86418 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.57703 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
4.9765 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PPARA, SRC, TEK |
4.89311 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
ADRB1, EGFR, ERBB2, INSR, KDR, KIT, SMAD3 |
4.60495 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.47254 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, SRC |
4.28299 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.25858 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PTAFR, PTPRS, SLC1A1, SRC, TEK, TUBB3, XDH |
4.10632 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.01679 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, ERBB2, HMGCR, MET, PPARA, SMAD3 |
3.84721 |
[MF] GO:0004672 |
protein kinase activity
|
CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, SRC, TEK |
3.8172 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.55739 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B1, SRC, XDH |
3.39845 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HMGCR, HSD17B1, XDH |
3.387 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, ERBB2, IGF1R, INSR, KDR, TEK |
3.33637 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, SLC1A1, SRC, TEK, TUBB3, XDH |
3.31478 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.31478 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, SRC, TEK |
3.13035 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR |
3.0886 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
3.00537 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.97677 |
[MF] GO:0019899 |
enzyme binding
|
ADRB1, APP, BCL2, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ERBB2, GRM5, HMGCR, HSPA1A, KIT, MET, PPARA, PTAFR, SMAD3, SRC, TEK, TNKS2 |
2.96334 |
[MF] GO:0016301 |
kinase activity
|
CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, SRC, TEK |
2.79228 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.63732 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.61502 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.61502 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.61462 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ABCB1, ADORA1, APP, CSNK2A1, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PTAFR, PTPRS, SRC, TEK, TUBB3 |
2.54036 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, ERBB2, HMGCR, MET |
2.52374 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, SMAD3, SRC |
2.48499 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, MMP12, PPARA, RORC, SMAD3, TNKS |
2.40974 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.383 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.383 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, ERBB2, KIT, MET |
2.38145 |
[MF] GO:0035586 |
None
|
ADORA1, ADORA3, PTAFR |
2.33862 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, PPARA, SMAD3, SRC |
2.33862 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, ERBB2, KIT, MET |
2.32537 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALPL, APP, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, KIT, MMP12, NUAK1, PPARA, RORC, SLC1A1, SMAD3, TNKS, TNKS2, XDH |
2.30363 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, CBR1, HMGCR, HSD17B1, XDH |
2.30363 |
[MF] GO:0000166 |
nucleotide binding
|
ABCB1, CSNK2A1, EGFR, ERBB2, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, SRC, TEK, TUBB3, XDH |
2.26727 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
ABCB1, CSNK2A1, EGFR, ERBB2, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, SRC, TEK, TUBB3, XDH |
2.26649 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, SRC, TEK |
2.26425 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
EGFR, ERBB2, KIT, MET |
2.23304 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.2189 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALPL, APP, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, KIT, MMP12, NUAK1, PPARA, RORC, SLC1A1, SMAD3, TNKS, TNKS2, XDH |
2.11391 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.08353 |
[MF] GO:0005088 |
Ras guanyl-nucleotide exchange factor activity
|
ADRB1, EGFR, ERBB2, KIT, MET, TEK |
2.07612 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, GRIK5, HMGCR, IGF1R, KDR, KIT, MET, SMAD3, XDH |
2.02001 |